• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

HealthTap Lawsuit Alleged VC Manipulation in Startup Valuations

by Fred Pennic 12/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
HealthTap Enters DME Market with Aeroflow Healthcare

What You Should Know: 

– Shareholders of HealthTap, Inc., a once-promising telehealth company, have filed a lawsuit against Mohr Davidow Ventures (MDV) and its affiliates, alleging breaches of fiduciary duty and a scheme to dilute minority shareholders and take over the company at a significantly depressed valuation.

– The lawsuit claims that MDV, as the controlling shareholder of HealthTap, orchestrated a series of actions that intentionally drove down the company’s value, creating artificial liquidity crises to justify self-interested financing rounds that benefited MDV at the expense of other shareholders.

Allegations of Mismanagement and Self-Dealing

Key allegations include:

  • Gutting the core business: MDV allegedly forced HealthTap to abandon its successful enterprise business model, focusing instead on a less profitable direct-to-consumer approach. This move, according to the lawsuit, intentionally drove down the company’s valuation.
  • Manufacturing liquidity crises: The lawsuit claims that MDV wasted company funds and created artificial financial distress to justify the need for additional financing on terms favorable to MDV.
  • Conflicted financing transactions: MDV allegedly used its control over the board to approve self-interested financing rounds that diluted minority shareholders and allowed MDV to acquire a majority stake in HealthTap at a significantly depressed valuation.
  • Misleading disclosures: The lawsuit claims that MDV and the board misled shareholders about the company’s financial condition and the fairness of the financing transactions.

Impact on Minority Shareholders

As a result of these alleged actions, the plaintiffs, who are minority shareholders in HealthTap, claim their ownership has been significantly diluted. They allege that MDV now holds the vast majority of the company’s equity, while their own stake has been reduced to a small fraction of its original value.

Seeking Relief

The plaintiffs are seeking equitable relief and damages to remedy the alleged breaches of fiduciary duty. They are asking the court to:

  • Declare the financing transactions invalid.
  • Order MDV to disgorge any profits it made from the alleged misconduct.
  • Award damages to the plaintiffs for their losses.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |